CLL: Treatment and Management Strategies for Best Outcomes - Episode 9
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Related Content:
Understanding the Risk of Overtreatment in Prostate Cancer
Empowering the Immune System
Growing from Embarrassment to Admiration of My Mother’s Breast Cancer
Funding for Cancer Research: Hope in a State of Fear